Saito H
Department of Pharmacy, Kyoto University Hospital, Japan.
Yakugaku Zasshi. 1997 Aug;117(8):522-41. doi: 10.1248/yakushi1947.117.8_522.
Intestinal absorption and renal tubular secretion are transport processes determining the availability and the disposition of drugs in the body. In this review, our studies on the molecular and cell biological analyses of intestinal absorption and renal secretion of drugs are described. We evaluated the transepithelial transport and the cellular accumulation of peptide-like drugs such as beta-lactam antibiotics and bestatin (a dipeptide-like antineoplastic agent) in the human adenocarcinoma colon cell line, Caco-2, as an in vitro model for studying absorption mechanisms of these drugs. We have found that the transcellular transport of these peptide-like drugs is mediated by both the apically- and basolaterally-localized peptide transporters. To characterize molecular aspects of absorption of the peptide-like drugs, we studied cDNA cloning of H+/peptide cotransporters, PEPT1 and PEPT2, expressed in rats. The rat PEPT1 has been shown to mediate the H- coupled uphill transport of beta-lactam antibiotics across the brush-border membranes of the intestinal and renal epithelia. The rat PEPT2 is expressed predominantly in the kidney, but not in the intestine, mediating tubular reabsorption of the peptide-like drugs. We examined the transcellular transport of organic cations across monolayers of the kidney epithelial cell line, LLC-PK1. We have found that LLC-PK1 cells possess the H+/organic cation antiporter and the membrane potential-sensitive organic cation transporter in the apical and basolateral membranes, respectively, thereby tetraethylammonium (TEA) being transported unidirectionally from the basolateral to the apical side of the monolayers. We have isolated a cDNA encoding a rat kidney-specific organic cation transporter, OCT 2, which transports TEA in a H(+)-gradient independent manner, suggesting that OCT2 is localized to the basolateral membranes of renal tubular cells. In addition, a cDNA encoding a novel rat organic anion transporter, OAT-K1, has been cloned. OAT-K1 is expressed exclusively in the renal proximal tubules, and mediates the transport of methotrexate. Analyses of the molecular and cell biological mechanisms for drug absorption and secretion will provide information for the understanding of organ specific drug transport systems and for the development of drug design and/or drug delivery system.
肠道吸收和肾小管分泌是决定药物在体内可用性和处置方式的转运过程。在本综述中,描述了我们对药物肠道吸收和肾脏分泌的分子及细胞生物学分析的研究。我们评估了在人结肠腺癌细胞系Caco-2中肽类药物(如β-内酰胺抗生素和贝他汀(一种二肽类抗肿瘤剂))的跨上皮转运和细胞内蓄积,将其作为研究这些药物吸收机制的体外模型。我们发现这些肽类药物的跨细胞转运是由顶端和基底外侧定位的肽转运体介导的。为了表征肽类药物吸收的分子方面,我们研究了在大鼠中表达的H⁺/肽共转运体PEPT1和PEPT2的cDNA克隆。已证明大鼠PEPT1介导β-内酰胺抗生素跨肠道和肾脏上皮刷状缘膜的H⁺偶联上坡转运。大鼠PEPT2主要在肾脏中表达,而不在肠道中表达,介导肽类药物的肾小管重吸收。我们研究了有机阳离子跨肾上皮细胞系LLC-PK1单层的跨细胞转运。我们发现LLC-PK1细胞在顶端和基底外侧膜中分别具有H⁺/有机阳离子反向转运体和膜电位敏感的有机阳离子转运体,从而使四乙铵(TEA)从单层的基底外侧单向转运至顶端侧。我们分离出了编码大鼠肾脏特异性有机阳离子转运体OCT 2的cDNA,它以不依赖H⁺梯度的方式转运TEA,表明OCT2定位于肾小管细胞的基底外侧膜。此外,还克隆了编码新型大鼠有机阴离子转运体OAT-K1的cDNA。OAT-K1仅在肾近端小管中表达,并介导甲氨蝶呤的转运。对药物吸收和分泌的分子及细胞生物学机制的分析将为理解器官特异性药物转运系统以及药物设计和/或药物递送系统的开发提供信息。